This video presents a case study of a deep soft tissue mass in a 15-year-old female, diagnosed as Alveolar Rhabdomyosarcoma (ARMS). The presentation highlights the variable histology of ARMS, which is characterized as a round blue cell tumor with prominent fibrovascular septa separating discohesive tumor nests. The speaker discusses key diagnostic morphological features, including rhabdoid cells and the important but often elusive multi-nucleated wreath cells. Emphasis is placed on the differential diagnosis with Embryonal Rhabdomyosarcoma (ERMS) and the necessity of molecular confirmation. ARMS is molecularly defined by t(1;13) or t(2;13) translocations involving PAX3/PAX7 and FOXO1. The video concludes by reviewing the crucial immunohistochemistry pattern: diffuse nuclear positivity for Myogenin (MYF4) and MyoD1, which differentiates ARMS from ERMS.
Summarizing the Case of Alveolar Rhabdomyosarcoma
0:08 Case Introduction & Diagnosis: The case involves a 15-year-old female with a deep soft tissue mass of the leg, diagnosed as Alveolar Rhabdomyosarcoma (ARMS).
0:37 Key Histological Features: ARMS is a round blue cell tumor characterized by very prominent fibrovascular septa that divide the tumor cells into distinct nests.
Detail: These nests often become "discohesive" (break apart), creating the alveolar appearance, although solid areas can occur, which may confuse diagnosis.
Takeaway: The combination of a round blue cell tumor with prominent fibrovascular septa strongly suggests ARMS.
1:14 Cellular Morphology: Tumor cells are round and blue. Some may show eosinophilic cytoplasm, giving them a "rhabdoid" appearance. Actual rhabdomyoblasts (strap cells, often seen in Embryonal Rhabdomyosarcoma) may be scattered but are rare.
2:11 Diagnostic Marker Cells: Multi-nucleated "wreath cells" are diagnostically helpful. These cells feature pink centers with nuclei arranged around the outside.
3:29 Clinical Context: ARMS tends to occur in children and young adults, and it is generally considered more aggressive than Embryonal Rhabdomyosarcoma (ERMS).
3:52 Molecular Abnormality: The definitive diagnosis requires molecular confirmation of translocations: t(1;13) or t(2;13).
Detail: These translocations involve the PAX3 or PAX7 genes partnering with FOXO1.
Takeaway: Molecular analysis is crucial for differentiation from ERMS because treatment protocols and prognoses differ significantly between the two subtypes.
4:36 Immunohistochemistry (IHC) Pattern: Expected staining includes diffuse positivity for Desmin and strong, diffuse nuclear positivity for Myogenin (MYF4) and MyoD1.
Takeaway: Diffuse nuclear staining (90% or more of cells positive) for Myogenin/MyoD1 is characteristic of ARMS, contrasting with the often patchy staining seen in ERMS.